1. Home
  2. RCMT vs VRXA Comparison

RCMT vs VRXA Comparison

Compare RCMT & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

N/A

Current Price

$41.18

Market Cap

297.5M

ML Signal

N/A

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$1.76

Market Cap

263.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RCMT
VRXA
Founded
1971
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.5M
263.0M
IPO Year
1997
2025

Fundamental Metrics

Financial Performance
Metric
RCMT
VRXA
Price
$41.18
$1.76
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$36.00
N/A
AVG Volume (30 Days)
86.7K
183.2K
Earning Date
04-03-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
27.38
N/A
EPS
1.20
N/A
Revenue
$186,737,000.00
N/A
Revenue This Year
$11.89
N/A
Revenue Next Year
$12.46
N/A
P/E Ratio
$34.11
N/A
Revenue Growth
5.83
N/A
52 Week Low
$17.26
$1.27
52 Week High
$43.09
$4.50

Technical Indicators

Market Signals
Indicator
RCMT
VRXA
Relative Strength Index (RSI) 70.64 37.49
Support Level $18.28 N/A
Resistance Level N/A $2.29
Average True Range (ATR) 1.84 0.17
MACD -0.07 -0.01
Stochastic Oscillator 69.45 37.67

Price Performance

Historical Comparison
RCMT
VRXA

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: